Black History Month Conversation with The Cancer Letter

University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center

By Amy Lacey, Otis W. Brawley and Paul Goldberg

A month after reporting to work in the top job at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Taofeek K. Owonikoko reflected on the obligations that come with being a Black director of an NCI-designated cancer center.

University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center

Delay in passing the FY24 budget is “disastrous for our cancer centers”

Patient navigation, financial toxicity top the agenda as Jill Biden, Kimryn Rathmell visit Atrium Health Wake Forest

SABCS: 46 years at the forefront of clinical and translational research in breast cancer—and still growing

Making history: Black women in oncology

In Brief

Monica Baskin named deputy director of UPMC Hillman

Steven Rosenberg to receive 2024 AACR Award for Lifetime Achievement in Cancer Research

James Allan named chair of Foundation for Biomedical Research board of directors

University of Cincinnati opens blood cancer healing center

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

FTC launches investigation of the roles GPOs, wholesalers play in causing drug shortages

Clinical Roundup

Novel drug combination shows promise in advanced HER2-negative breast cancer treatment

New immunotherapy for multiple myeloma proves in the lab to be more effective than CAR T treatment already in use

Patient-reported outcomes indicate improved physical function for complete responders in phase II/III bladder cancer study

Plant-based diet tied to improved sexual health during prostate cancer treatment

Decoding the genes behind dolastatin 10 paves the way for new cancer therapeutics

ACS CAN survey finds affordability is the leading policy priority for cancer patients and survivors

Drugs & Targets

FDA approves Onivyde for first-line treatment of metastatic pancreatic adenocarcinoma

FDA grants Augtyro priority review for NTRK-positive locally advanced or metastatic solid tumors

MD Anderson, C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy

BioNTech, Autolus form CAR T-cell therapy collaboration to advance pipeline and expand late-stage programs

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login